Autophagosome protects proximal tubular cells from aldosterone-induced senescence through improving oxidative stress

References

• He S, Sharpless NE. Senescence in health and disease. Cell. 2017;169(6):1000–1011.
   PubMed Web of Science ®Google Scholar
• Schmitt R, Melk A. Molecular mechanisms of renal aging. Kidney Int. 2017;92(3):569–579.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhou L. The signaling of cellular senescence in diabetic nephropathy. Oxid Med Cell Longev. 2019;2019:7495629.
   PubMed Web of Science ®Google Scholar
• Gekle M. Kidney and aging - a narrative review. Exp Gerontol. 2017;87(Pt B):153–155.
   PubMedGoogle Scholar
• Jennings P, Koppelstaetter C, Aydin S, et al. Cyclosporine A induces senescence in renal tubular epithelial cells. Am J Physiol Renal Physiol. 2007;293(3):F831–838.
   PubMed Web of Science ®Google Scholar
• Briet M, Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol. 2010;6(5):261–273.
   PubMed Web of Science ®Google Scholar
• Kim YY, Jee HJ, Um JH, et al. Cooperation between p21 and Akt is required for p53-dependent cellular senescence. Aging Cell. 2017;16(5):1094–1103.
   PubMed Web of Science ®Google Scholar
• Bazopoulou D, Knoefler D, Zheng Y, et al. Developmental ROS individualizes organismal stress resistance and lifespan. Nature. 2019;576(7786):301–305.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Vikash V, et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016;2016:4350965.
   PubMed Web of Science ®Google Scholar
• Ding W, Guo H, Xu C, et al. Mitochondrial reactive oxygen species-mediated NLRP3 inflammasome activation contributes to aldosterone-induced renal tubular cells injury. Oncotarget. 2016;7(14):17479–17491.
   PubMedGoogle Scholar
• Wang B, Xu X, He X, et al. Berberine improved aldo-induced podocyte injury via inhibiting oxidative stress and endoplasmic reticulum stress pathways both in vivo and in vitro. Cell Physiol Biochem. 2016;39(1):217–228.
   PubMedGoogle Scholar
• Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19(6):349–364.
   PubMed Web of Science ®Google Scholar
• Rajendran P, Alzahrani AM, Hanieh HN, et al. Autophagy and senescence: a new insight in selected human diseases. J Cell Physiol. 2019;234(12):21485–21492.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Mariño G, Kroemer G. Autophagy and aging. Cell. 2011;146(5):682–695.
   PubMed Web of Science ®Google Scholar
• Ding W, Xu C, Wang B, et al. Rotenone attenuates renal injury in aldosterone-infused rats by inhibiting oxidative stress, mitochondrial dysfunction, and inflammasome activation. Med Sci Monit. 2015;21:3136–3143.
   PubMed Web of Science ®Google Scholar
• Mauthe M, Orhon I, Rocchi C, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435–1455.
   PubMed Web of Science ®Google Scholar
• Babchia N, Calipel A, Mouriaux F, Faussat AM, et al. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Invest Ophthalmol Vis Sci. 2010;51(1):421–429.
   PubMed Web of Science ®Google Scholar
• Fan YY, Kohno M, Hitomi H, et al. Aldosterone/Mineralocorticoid receptor stimulation induces cellular senescence in the kidney. Endocrinology. 2011;152(2):680–688.
   PubMed Web of Science ®Google Scholar
• Nagase M, Fujita T. Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease. Nat Rev Nephrol. 2013;9(2):86–98.
   PubMed Web of Science ®Google Scholar
• Lerman LO. Imaging: BOLD assessment-effects of RAAS inhibition in CKD. Nat Rev Nephrol. 2014;10(5):247–248.
   PubMed Web of Science ®Google Scholar
• Zhang Y, He D, Zhang W, et al. ACE inhibitor benefit to kidney and cardiovascular outcomes for patients with non-dialysis chronic kidney disease stages 3–5: a network meta-analysis of randomised clinical trials. Drugs. 2020;80(8):797–811.
   PubMed Web of Science ®Google Scholar
• Baltatzi M, Savopoulos C, Hatzitolios A. Role of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension of chronic kidney disease and renoprotection. Study results. Hippokratia. 2011;15(Suppl 1):27–32.
   PubMedGoogle Scholar
• Staessen J, Lijnen P, Fagard R, et al. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol. 1981;91(3):457–465.
   PubMed Web of Science ®Google Scholar
• Hostetter TH, Ibrahim HN. Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol. 2003;14(9):2395–2401.
   PubMed Web of Science ®Google Scholar
• Brem AS, Gong R. Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease. Clin Sci (Lond). 2015;128(9):527–535.
   PubMed Web of Science ®Google Scholar
• Nishiyama A, Kusaka T, Kitajima H. [Role of aldosterone in oxidative stress and renal injury]. Yakugaku Zasshi. 2007;127(9):1331–1337.
   PubMed Web of Science ®Google Scholar
• Wang B, Ding W, Zhang M, et al. Rapamycin attenuates aldosterone-induced tubulointerstitial inflammation and fibrosis. Cell Physiol Biochem. 2015;35(1):116–125.
   PubMedGoogle Scholar
• Infante B, Franzin R, Madio D, et al. Molecular mechanisms of AKI in the elderly: from animal models to therapeutic intervention. JCM. 2020;9(8):2574.
   Google Scholar
• Franzin R, Stasi A, Fiorentino M, et al. Inflammaging and complement system: a link between acute kidney injury and chronic graft damage. Front Immunol. 2020;11:734.
   PubMed Web of Science ®Google Scholar
• Castellano G, Franzin R, Sallustio F, et al. Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury. Aging (Albany NY). 2019;11(13):4382–4406.
   PubMedGoogle Scholar
• Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–E462.
   PubMed Web of Science ®Google Scholar
• Yang M, Wang B, Li M, et al. Connexin 43 is involved in aldosterone-induced podocyte injury. Cell Physiol Biochem. 2014;34(5):1652–1662.
   PubMedGoogle Scholar
• Li L, Tan J, Miao Y, et al. ROS and autophagy: interactions and molecular regulatory mechanisms. Cell Mol Neurobiol. 2015;35(5):615–621.
   PubMed Web of Science ®Google Scholar
• Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22(3):377–388.
   PubMed Web of Science ®Google Scholar
• Sureshbabu A, Ryter SW, Choi ME. Oxidative stress and autophagy: crucial modulators of kidney injury. Redox Biol. 2015;4:208–214.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Baehrecke EH, Ballabio A, et al. Molecular definitions of autophagy and related processes. Embo J. 2017;36(13):1811–1836.
   PubMed Web of Science ®Google Scholar